BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hariharan A, Hakeem AR, Radhakrishnan S, Reddy MS, Rela M. The Role and Therapeutic Potential of NF-kappa-B Pathway in Severe COVID-19 Patients. Inflammopharmacology. 2021;29:91-100. [PMID: 33159646 DOI: 10.1007/s10787-020-00773-9] [Cited by in Crossref: 43] [Cited by in F6Publishing: 43] [Article Influence: 21.5] [Reference Citation Analysis]
Number Citing Articles
1 Khanh VC, Fukushige M, Chang YH, Hoang NN, Yamashita T, Obata-Yasuoka M, Hamada H, Osaka M, Hiramatsu Y, Ohneda O. Wharton's Jelly Mesenchymal Stem Cell-Derived Extracellular Vesicles Reduce SARS-CoV2-Induced Inflammatory Cytokines Under High Glucose and Uremic Toxin Conditions. Stem Cells Dev 2021;30:758-72. [PMID: 34074129 DOI: 10.1089/scd.2021.0065] [Reference Citation Analysis]
2 Nezametdinova VZ, Yunes RA, Dukhinova MS, Alekseeva MG, Danilenko VN. The Role of the PFNA Operon of Bifidobacteria in the Recognition of Host's Immune Signals: Prospects for the Use of the FN3 Protein in the Treatment of COVID-19. Int J Mol Sci 2021;22:9219. [PMID: 34502130 DOI: 10.3390/ijms22179219] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Alkan G, Artac H, Oz SKT, Emiroglu M. Management of COVID-19 pneumonia in a child with NEMO deficiency. Immunol Res 2021;69:391-3. [PMID: 34061330 DOI: 10.1007/s12026-021-09184-6] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
4 Chen P, Tang Y, He W, Yang R, Lan Z, Chen R, Zhang P, Yokota S. Potential Pathophysiological Mechanisms Underlying Multiple Organ Dysfunction in Cytokine Release Syndrome. Mediators of Inflammation 2022;2022:1-17. [DOI: 10.1155/2022/7137900] [Reference Citation Analysis]
5 Zhang J, Tecson KM, McCullough PA. Role of endothelial cell receptors in the context of SARS-CoV-2 infection (COVID-19). Proc (Bayl Univ Med Cent) 2021;34:262-8. [PMID: 33664552 DOI: 10.1080/08998280.2021.1874231] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Elahi R, Karami P, Heidary AH, Esmaeilzadeh A. An updated overview of recent advances, challenges, and clinical considerations of IL-6 signaling blockade in severe coronavirus disease 2019 (COVID-19). International Immunopharmacology 2022;105:108536. [DOI: 10.1016/j.intimp.2022.108536] [Reference Citation Analysis]
7 Luo MH, Qian YQ, Huang DL, Luo JC, Su Y, Wang H, Yu SJ, Liu K, Tu GW, Luo Z. Tailoring glucocorticoids in patients with severe COVID-19: a narrative review. Ann Transl Med 2021;9:1261. [PMID: 34532398 DOI: 10.21037/atm-21-1783] [Reference Citation Analysis]
8 Ebrahimi M, Farhadian N, Amiri AR, Hataminia F, Soflaei SS, Karimi M. Evaluating the efficacy of extracted squalene from seed oil in the form of microemulsion for the treatment of COVID-19: A clinical study. J Med Virol 2021. [PMID: 34403141 DOI: 10.1002/jmv.27273] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
9 Farahani M, Niknam Z, Mohammadi Amirabad L, Amiri-Dashatan N, Koushki M, Nemati M, Danesh Pouya F, Rezaei-Tavirani M, Rasmi Y, Tayebi L. Molecular pathways involved in COVID-19 and potential pathway-based therapeutic targets. Biomed Pharmacother 2022;145:112420. [PMID: 34801852 DOI: 10.1016/j.biopha.2021.112420] [Reference Citation Analysis]
10 Al-Kuraishy HM, Al-Gareeb AI, Alqarni M, Cruz-Martins N, El-Saber Batiha G. Pleiotropic Effects of Tetracyclines in the Management of COVID-19: Emerging Perspectives. Front Pharmacol 2021;12:642822. [PMID: 33967777 DOI: 10.3389/fphar.2021.642822] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
11 Zarrilli G, Angerilli V, Businello G, Sbaraglia M, Traverso G, Fortarezza F, Rizzo S, De Gaspari M, Basso C, Calabrese F, Dei Tos AP, Fassan M. The Immunopathological and Histological Landscape of COVID-19-Mediated Lung Injury. Int J Mol Sci 2021;22:974. [PMID: 33478107 DOI: 10.3390/ijms22020974] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
12 Hasanvand A. COVID-19 and the role of cytokines in this disease. Inflammopharmacology 2022. [PMID: 35505267 DOI: 10.1007/s10787-022-00992-2] [Reference Citation Analysis]
13 Fakhoury HMA, Kvietys PR, Shakir I, Shams H, Grant WB, Alkattan K. Lung-Centric Inflammation of COVID-19: Potential Modulation by Vitamin D. Nutrients 2021;13:2216. [PMID: 34203190 DOI: 10.3390/nu13072216] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Brocke SA, Billings GT, Taft-Benz S, Alexis NE, Heise MT, Jaspers I. Woodsmoke particulates alter expression of antiviral host response genes in human nasal epithelial cells infected with SARS-CoV-2 in a sex-dependent manner. bioRxiv 2021:2021. [PMID: 34462747 DOI: 10.1101/2021.08.23.457411] [Reference Citation Analysis]
15 Olajide OA, Iwuanyanwu VU, Lepiarz-Raba I, Al-Hindawi AA, Aderogba MA, Sharp HL, Nash RJ. Garcinia kola and garcinoic acid suppress SARS-CoV-2 spike glycoprotein S1-induced hyper-inflammation in human PBMCs through inhibition of NF-κB activation. Phytother Res 2021. [PMID: 34697842 DOI: 10.1002/ptr.7315] [Reference Citation Analysis]
16 Mukherjee S, Banerjee B, Karasik D, Frenkel-Morgenstern M. mRNA-lncRNA Co-Expression Network Analysis Reveals the Role of lncRNAs in Immune Dysfunction during Severe SARS-CoV-2 Infection. Viruses 2021;13:402. [PMID: 33802569 DOI: 10.3390/v13030402] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
17 Samad N, Dutta S, Sodunke TE, Fairuz A, Sapkota A, Miftah ZF, Jahan I, Sharma P, Abubakar AR, Rowaiye AB, Oli AN, Charan J, Islam S, Haque M. Fat-Soluble Vitamins and the Current Global Pandemic of COVID-19: Evidence-Based Efficacy from Literature Review. J Inflamm Res 2021;14:2091-110. [PMID: 34045883 DOI: 10.2147/JIR.S307333] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
18 Khatua S, Simal-Gandara J, Acharya K. Understanding immune-modulatory efficacy in vitro. Chem Biol Interact 2021;352:109776. [PMID: 34906553 DOI: 10.1016/j.cbi.2021.109776] [Reference Citation Analysis]
19 Gupta A, Marzook H, Ahmad F. Comorbidities and clinical complications associated with SARS-CoV-2 infection: an overview. Clin Exp Med 2022. [PMID: 35362771 DOI: 10.1007/s10238-022-00821-4] [Reference Citation Analysis]
20 Lauro R, Irrera N, Eid AH, Bitto A. Could Antigen Presenting Cells Represent a Protective Element during SARS-CoV-2 Infection in Children? Pathogens 2021;10:476. [PMID: 33920011 DOI: 10.3390/pathogens10040476] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
21 Rabaan AA, Al-Ahmed SH, Garout MA, Al-Qaaneh AM, Sule AA, Tirupathi R, Mutair AA, Alhumaid S, Hasan A, Dhawan M, Tiwari R, Sharun K, Mohapatra RK, Mitra S, Emran TB, Bilal M, Singh R, Alyami SA, Moni MA, Dhama K. Diverse Immunological Factors Influencing Pathogenesis in Patients with COVID-19: A Review on Viral Dissemination, Immunotherapeutic Options to Counter Cytokine Storm and Inflammatory Responses. Pathogens 2021;10:565. [PMID: 34066983 DOI: 10.3390/pathogens10050565] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 8.0] [Reference Citation Analysis]
22 Barilli A, Visigalli R, Ferrari F, Bianchi MG, Dall’asta V, Rotoli BM. Immune-Mediated Inflammatory Responses of Alveolar Epithelial Cells: Implications for COVID-19 Lung Pathology. Biomedicines 2022;10:618. [DOI: 10.3390/biomedicines10030618] [Reference Citation Analysis]
23 Dejani NN, Elshabrawy HA, Bezerra Filho CDSM, de Sousa DP. Anticoronavirus and Immunomodulatory Phenolic Compounds: Opportunities and Pharmacotherapeutic Perspectives. Biomolecules 2021;11:1254. [PMID: 34439920 DOI: 10.3390/biom11081254] [Reference Citation Analysis]
24 Liskova A, Koklesova L, Samec M, Abdellatif B, Zhai K, Siddiqui M, Šudomová M, Hassan STS, Kudela E, Biringer K, Giordano FA, Büsselberg D, Golubnitschaja O, Kubatka P. Targeting phytoprotection in the COVID-19-induced lung damage and associated systemic effects-the evidence-based 3PM proposition to mitigate individual risks. EPMA J 2021;:1-23. [PMID: 34367380 DOI: 10.1007/s13167-021-00249-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
25 Yu C, Dong H, Wang Q, Bai J, Li YN, Zhao JJ, Li JZ. Danshensu attenuates cisplatin-induced nephrotoxicity through activation of Nrf2 pathway and inhibition of NF-κB. Biomed Pharmacother 2021;142:111995. [PMID: 34435595 DOI: 10.1016/j.biopha.2021.111995] [Reference Citation Analysis]
26 Peter AE, Sandeep BV, Rao BG, Kalpana VL. Nanotechnology to the Rescue: Treatment Perspective for the Immune Dysregulation Observed in COVID-19. Front Nanotechnol 2021;3:644023. [DOI: 10.3389/fnano.2021.644023] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
27 Guo J, Zhao X, Liu Z, Liu D, Tang X, Wang K, Wang M, Huang Y, Tong D. Transmissible gastroenteritis virus ORF3b up-regulates miR-885-3p to counteract TNF-α production via inhibiting NF-κB pathway. Vet Microbiol 2021;261:109189. [PMID: 34375914 DOI: 10.1016/j.vetmic.2021.109189] [Reference Citation Analysis]
28 Yang Q, Lin F, Wang Y, Zeng M, Luo M. Long Noncoding RNAs as Emerging Regulators of COVID-19. Front Immunol 2021;12:700184. [PMID: 34408749 DOI: 10.3389/fimmu.2021.700184] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
29 Gopalaswamy R, Subbian S. Corticosteroids for COVID-19 Therapy: Potential Implications on Tuberculosis. Int J Mol Sci 2021;22:3773. [PMID: 33917321 DOI: 10.3390/ijms22073773] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
30 Yang L, Xie X, Tu Z, Fu J, Xu D, Zhou Y. The signal pathways and treatment of cytokine storm in COVID-19. Signal Transduct Target Ther 2021;6:255. [PMID: 34234112 DOI: 10.1038/s41392-021-00679-0] [Cited by in F6Publishing: 8] [Reference Citation Analysis]
31 Barh D, Aljabali AA, Tambuwala MM, Tiwari S, Serrano-Aroca Á, Alzahrani KJ, Silva Andrade B, Azevedo V, Ganguly NK, Lundstrom K. Predicting COVID-19-Comorbidity Pathway Crosstalk-Based Targets and Drugs: Towards Personalized COVID-19 Management. Biomedicines 2021;9:556. [PMID: 34067609 DOI: 10.3390/biomedicines9050556] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
32 Preethi L, Ganamurali N, Dhanasekaran D, Sabarathinam S. Therapeutic use of Guggulsterone in COVID-19 induced obesity (COVIBESITY) and significant role in immunomodulatory effect. Obes Med 2021;24:100346. [PMID: 33942025 DOI: 10.1016/j.obmed.2021.100346] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
33 Saygili E, Yildiz-Ozturk E, Green MJ, Ghaemmaghami AM, Yesil-Celiktas O. Human lung-on-chips: Advanced systems for respiratory virus models and assessment of immune response. Biomicrofluidics 2021;15:021501. [PMID: 33791050 DOI: 10.1063/5.0038924] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
34 Paul S, Bravo Vázquez LA, Reyes-Pérez PR, Estrada-Meza C, Aponte Alburquerque RA, Pathak S, Banerjee A, Bandyopadhyay A, Chakraborty S, Srivastava A. The role of microRNAs in solving COVID-19 puzzle from infection to therapeutics: A mini-review. Virus Res 2021;308:198631. [PMID: 34788642 DOI: 10.1016/j.virusres.2021.198631] [Reference Citation Analysis]
35 Thota S, Begum R, Kaur G, Bagam P, Dorsey W, Batra S. Pentachlorophenol mediated regulation of DAMPs and inflammation: In vitro study. Toxicol In Vitro 2022;:105378. [PMID: 35550411 DOI: 10.1016/j.tiv.2022.105378] [Reference Citation Analysis]
36 Lara-Ureña N, García-Domínguez M. Relevance of BET Family Proteins in SARS-CoV-2 Infection. Biomolecules 2021;11:1126. [PMID: 34439792 DOI: 10.3390/biom11081126] [Reference Citation Analysis]
37 Deek SA. BPC 157 as Potential Treatment for COVID-19. Med Hypotheses 2021;158:110736. [PMID: 34798584 DOI: 10.1016/j.mehy.2021.110736] [Reference Citation Analysis]
38 Zhu DD, Tan XM, Lu LQ, Yu SJ, Jian RL, Liang XF, Liao YX, Fan W, Barbier-Torres L, Yang A, Yang HP, Liu T. Interplay between nuclear factor erythroid 2-related factor 2 and inflammatory mediators in COVID-19-related liver injury. World J Gastroenterol 2021; 27(22): 2944-2962 [PMID: 34168400 DOI: 10.3748/wjg.v27.i22.2944] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
39 O'Donnell KL, Pinski AN, Clancy CS, Gourdine T, Shifflett K, Fletcher P, Messaoudi I, Marzi A. Pathogenic and transcriptomic differences of emerging SARS-CoV-2 variants in the Syrian golden hamster model. EBioMedicine 2021;73:103675. [PMID: 34758415 DOI: 10.1016/j.ebiom.2021.103675] [Reference Citation Analysis]
40 Banaganapalli B, Al-Rayes N, Awan ZA, Alsulaimany FA, Alamri AS, Elango R, Malik MZ, Shaik NA. Multilevel systems biology analysis of lung transcriptomics data identifies key miRNAs and potential miRNA target genes for SARS-CoV-2 infection. Comput Biol Med 2021;135:104570. [PMID: 34157472 DOI: 10.1016/j.compbiomed.2021.104570] [Reference Citation Analysis]
41 Kvietys PR, Fakhoury HMA, Kadan S, Yaqinuddin A, Al-Mutairy E, Al-Kattan K. COVID-19: Lung-Centric Immunothrombosis. Front Cell Infect Microbiol 2021;11:679878. [PMID: 34178722 DOI: 10.3389/fcimb.2021.679878] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
42 Alqathama AA, Ahmad R, Alsaedi RB, Alghamdi RA, Abkar EH, Alrehaly RH, Abdalla AN. The vital role of animal, marine, and microbial natural products against COVID-19. Pharm Biol 2022;60:509-24. [PMID: 35234563 DOI: 10.1080/13880209.2022.2039215] [Reference Citation Analysis]
43 Spinelli G, Biddeci G, Artale A, Valentino F, Tarantino G, Gallo G, Gianguzza F, Conaldi PG, Corrao S, Gervasi F, Aronica TS, Di Leonardo A, Duro G, Di Blasi F. A new p65 isoform that bind the glucocorticoid hormone and is expressed in inflammation liver diseases and COVID-19. Sci Rep 2021;11:22913. [PMID: 34824310 DOI: 10.1038/s41598-021-02119-z] [Reference Citation Analysis]
44 Sharma VK, Prateeksha, Singh SP, Singh BN, Rao CV, Barik SK. Nanocurcumin Potently Inhibits SARS-CoV-2 Spike Protein-Induced Cytokine Storm by Deactivation of MAPK/NF-κB Signaling in Epithelial Cells. ACS Appl Bio Mater 2022. [PMID: 35112841 DOI: 10.1021/acsabm.1c00874] [Reference Citation Analysis]
45 Arancibia-Hernández YL, Aranda-Rivera AK, Cruz-Gregorio A, Pedraza-Chaverri J. Antioxidant/anti-inflammatory effect of Mg2+ in coronavirus disease 2019 (COVID-19). Rev Med Virol 2022;:e2348. [PMID: 35357063 DOI: 10.1002/rmv.2348] [Reference Citation Analysis]
46 Feng Y, Zhu B, Liu Y, Liu Y, Zhou G, Yang L, Liu L, Ren J, Hou Y, Yu H, Meng P, Jiang Y, Wang X. Yindan Jiedu granules exhibit anti-inflammatory effect in patients with novel Coronavirus disease (COVID-19) by suppressing the NF-κB signaling pathway. Phytomedicine 2021;:153784. [PMID: 34785108 DOI: 10.1016/j.phymed.2021.153784] [Reference Citation Analysis]
47 Rezaei Z, Mobasheri L, Sadri F. Molecular Insights into COVID-19 Pathophysiology, Immune Pathogenesis, Detection, and Treatment. DNA Cell Biol 2021;40:858-68. [PMID: 33989051 DOI: 10.1089/dna.2021.0068] [Reference Citation Analysis]
48 Pandey A, Kulshrestha R, Bansal SK. Dynamic role of LMW-hyaluronan fragments and Toll-like receptors 2,4 in progression of bleomycin induced lung parenchymal injury to fibrosis. Egypt J Bronchol 2021;15. [DOI: 10.1186/s43168-021-00073-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
49 Chiang KC, Rizk JG, Nelson DJ, Krishnamurti L, Subbian S, Imig JD, Khan I, Reddy ST, Gupta A. Ramatroban for chemoprophylaxis and treatment of COVID-19: David takes on Goliath. Expert Opinion on Therapeutic Targets. [DOI: 10.1080/14728222.2022.2031975] [Reference Citation Analysis]
50 Brocke SA, Billings GT, Taft-Benz S, Alexis NE, Heise MT, Jaspers I. Woodsmoke particle exposure prior to SARS-CoV-2 infection alters antiviral response gene expression in human nasal epithelial cells in a sex-dependent manner. Am J Physiol Lung Cell Mol Physiol 2022. [PMID: 35107034 DOI: 10.1152/ajplung.00362.2021] [Reference Citation Analysis]
51 Ma Q, Lei B, Chen R, Liu B, Lu W, Jiang H, Chen Z, Guo X, Wang Y, Zhang L, Chen Q, Li X, Yang Z. Liushen Capsules, a promising clinical candidate for COVID-19, alleviates SARS-CoV-2-induced pulmonary in vivo and inhibits the proliferation of the variant virus strains in vitro. Chin Med 2022;17:40. [PMID: 35365215 DOI: 10.1186/s13020-022-00598-4] [Reference Citation Analysis]
52 Zhang Y, Chen S, Jin Y, Ji W, Zhang W, Duan G. An Update on Innate Immune Responses during SARS-CoV-2 Infection. Viruses 2021;13:2060. [PMID: 34696490 DOI: 10.3390/v13102060] [Reference Citation Analysis]
53 Li SX, Yan W, Liu JP, Zhao YJ, Chen L. Long noncoding RNA SNHG4 remits lipopolysaccharide-engendered inflammatory lung damage by inhibiting METTL3 - Mediated m6A level of STAT2 mRNA. Mol Immunol 2021;139:10-22. [PMID: 34450538 DOI: 10.1016/j.molimm.2021.08.008] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
54 Jiang C, Zhang J, Xie H, Guan H, Li R, Chen C, Dong H, Zhou Y, Zhang W. Baicalein suppresses lipopolysaccharide-induced acute lung injury by regulating Drp1-dependent mitochondrial fission of macrophages. Biomed Pharmacother 2022;145:112408. [PMID: 34801855 DOI: 10.1016/j.biopha.2021.112408] [Reference Citation Analysis]
55 Tapryal N, Shahabi S, Chakraborty A, Hosoki K, Wakamiya M, Sarkar G, Sharma G, Cardenas VJ, Boldogh I, Sur S, Ghosh G, Hazra TK. Intrapulmonary administration of purified NEIL2 abrogates NF-κB-mediated inflammation. J Biol Chem 2021;296:100723. [PMID: 33932404 DOI: 10.1016/j.jbc.2021.100723] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
56 Kircheis R. Coagulopathies after Vaccination against SARS-CoV-2 May Be Derived from a Combined Effect of SARS-CoV-2 Spike Protein and Adenovirus Vector-Triggered Signaling Pathways. Int J Mol Sci 2021;22:10791. [PMID: 34639132 DOI: 10.3390/ijms221910791] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
57 Parzibut G, Henket M, Moermans C, Struman I, Louis E, Malaise M, Louis R, Misset B, Njock MS, Guiot J. A Blood Exosomal miRNA Signature in Acute Respiratory Distress Syndrome. Front Mol Biosci 2021;8:640042. [PMID: 34336922 DOI: 10.3389/fmolb.2021.640042] [Reference Citation Analysis]
58 Nazari-Khanamiri F, Ghasemnejad-Berenji M. A hypothesis that Notopterol may be effective in COVID-19 via JAK/STAT and other signaling pathways. J Basic Clin Physiol Pharmacol 2022. [PMID: 35390234 DOI: 10.1515/jbcpp-2022-0028] [Reference Citation Analysis]
59 Salem F, Li XZ, Hindi J, Casablanca NM, Zhong F, El Jamal SM, Haroon Al Rasheed MR, Li L, Lee K, Chan L, He JC. Activation of STAT3 signaling pathway in the kidney of COVID-19 patients. J Nephrol 2021. [PMID: 34626364 DOI: 10.1007/s40620-021-01173-0] [Reference Citation Analysis]
60 Poutoglidou F, Saitis A, Kouvelas D. Ibuprofen and COVID-19 disease: separating the myths from facts. Expert Rev Respir Med 2021;15:979-83. [PMID: 34196258 DOI: 10.1080/17476348.2021.1951239] [Reference Citation Analysis]
61 Cheon SY, Koo BN. Inflammatory Response in COVID-19 Patients Resulting from the Interaction of the Inflammasome and SARS-CoV-2. Int J Mol Sci 2021;22:7914. [PMID: 34360684 DOI: 10.3390/ijms22157914] [Reference Citation Analysis]
62 Marmitt DJ. Potential plants for inflammatory dysfunction in the SARS-CoV-2 infection. Inflammopharmacology 2022. [PMID: 35389124 DOI: 10.1007/s10787-022-00981-5] [Reference Citation Analysis]
63 Rahimmanesh I, Shariati L, Dana N, Esmaeili Y, Vaseghi G, Haghjooy Javanmard S. Cancer Occurrence as the Upcoming Complications of COVID-19. Front Mol Biosci 2022;8:813175. [DOI: 10.3389/fmolb.2021.813175] [Reference Citation Analysis]
64 Rangon CM, Barruet R, Mazouni A, Le Cossec C, Thevenin S, Guillaume J, Léguillier T, Huysman F, Luis D. Auricular Neuromodulation for Mass Vagus Nerve Stimulation: Insights From SOS COVID-19 a Multicentric, Randomized, Controlled, Double-Blind French Pilot Study. Front Physiol 2021;12:704599. [PMID: 34408665 DOI: 10.3389/fphys.2021.704599] [Reference Citation Analysis]
65 Alqarni MH, Foudah AI, Muharram MM, Labrou NE. The Pleiotropic Function of Human Sirtuins as Modulators of Metabolic Pathways and Viral Infections. Cells 2021;10:460. [PMID: 33669990 DOI: 10.3390/cells10020460] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
66 Vázquez-Jiménez A, Avila-Ponce De León UE, Matadamas-Guzman M, Muciño-Olmos EA, Martínez-López YE, Escobedo-Tapia T, Resendis-Antonio O. On Deep Landscape Exploration of COVID-19 Patients Cells and Severity Markers. Front Immunol 2021;12:705646. [PMID: 34603282 DOI: 10.3389/fimmu.2021.705646] [Reference Citation Analysis]
67 Sunkara H, Dewan SMR. Coronavirus disease-2019: A review on the disease exacerbation via cytokine storm and concurrent management. Int Immunopharmacol 2021;99:108049. [PMID: 34426104 DOI: 10.1016/j.intimp.2021.108049] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
68 Norooznezhad AH, Mansouri K. Endothelial cell dysfunction, coagulation, and angiogenesis in coronavirus disease 2019 (COVID-19). Microvasc Res 2021;137:104188. [PMID: 34022205 DOI: 10.1016/j.mvr.2021.104188] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
69 Rasmi Y, Heidari N, Kübra Kırboğa K, Hatamkhani S, Tekin B, Alipour S, Naderi R, Farnamian Y, Akca I. The importance of neopterin in COVID-19: The prognostic value and relation with the disease severity. Clinical Biochemistry 2022. [DOI: 10.1016/j.clinbiochem.2022.03.002] [Reference Citation Analysis]
70 Kircheis R, Schuster M, Planz O. COVID-19: Mechanistic Model of the African Paradox Supports the Central Role of the NF-κB Pathway. Viruses 2021;13:1887. [PMID: 34578468 DOI: 10.3390/v13091887] [Reference Citation Analysis]
71 Crespo-Facorro B, Ruiz-Veguilla M, Vázquez-Bourgon J, Sánchez-Hidalgo AC, Garrido-Torres N, Cisneros JM, Prieto C, Sainz J. Aripiprazole as a Candidate Treatment of COVID-19 Identified Through Genomic Analysis. Front Pharmacol 2021;12:646701. [PMID: 33762960 DOI: 10.3389/fphar.2021.646701] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
72 Chiang KC, Imig JD, Kalantar-Zadeh K, Gupta A. Kidney in the net of acute and long-haul coronavirus disease 2019: a potential role for lipid mediators in causing renal injury and fibrosis. Curr Opin Nephrol Hypertens 2022;31:36-46. [PMID: 34846312 DOI: 10.1097/MNH.0000000000000750] [Reference Citation Analysis]